BNT326
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BNT326, covering 2025-10-22 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors [Phase 1, Phase 2]